医学
尿路上皮癌
癌症
肿瘤科
内科学
膀胱癌
妇科
泌尿科
作者
Elizabeth Nally,Matthew R. Young,Connor Wells,Rory Fairhead,Katherine J. Baines,Hannah Cheney-Lowe,Francesca Jackson‐Spence,Thomas Powles
标识
DOI:10.1016/j.euf.2024.05.018
摘要
Antibody-drug conjugates have transformed treatment for urothelial cancer (UC). Enfortumab vedotin is the new standard of care in the first-line setting for advanced UC. A personalised approach targeting HER2 in UC is currently being explored.
科研通智能强力驱动
Strongly Powered by AbleSci AI